Scientific EXPERT Act of 2025
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
The bill expands a appropriation, reporting req, compliance mandate provision: 2, expands a appropriation, compliance mandate, product standard provision: 770A. Science-focused drug development meetings, and expands a appropriation, reporting req, compliance mandate provision: 770B. It relies on appropriations, compliance mandates, reporting requirements, and product standards. The main policy areas are Healthcare.
Who Benefits and How
The available clause analysis does not identify a specific beneficiary group.
Who Bears the Burden and How
No clear private burden is identified from the available clause analysis; implementing agencies may still take on administrative work.
Key Provisions
- Expands a appropriation, reporting req, compliance mandate provision: 2.
- Expands a appropriation, compliance mandate, product standard provision: 770A. Science-focused drug development meetings.
- Expands a appropriation, reporting req, compliance mandate provision: 770B.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for primary purpose and policy domains.
At a Glance
What This Bill Does
The bill expands a appropriation, reporting req, compliance mandate provision: 2, expands a appropriation, compliance mandate, product standard provision: 770A. Science-focused drug development meetings, and expands a appropriation, reporting req, compliance mandate provision: 770B.
Key Policy Areas
Healthcare
Primary Purpose
The bill expands a appropriation, reporting req, compliance mandate provision: 2, expands a appropriation, compliance mandate, product standard provision: 770A. Science-focused drug development meetings, and expands a appropriation, reporting req, compliance mandate provision: 770B.
Policy Domains
Sponsors
Legislative Progress
In CommitteeMs. Matsui (for herself and Mr. Bilirakis) introduced the following …
Referred to the House Committee on Energy and Commerce.
Introduced in House
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_secretary"
- → The Secretary identified in the operative section
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology